RBC Capital Markets upgraded its rating on shares of Edwards Lifesciences Corp. (EW) Monday morning to "Outperform" from "Equal weight."
Edwards Lifesciences has gapped open sharply higher this morning and is now up 4.21 at $151.37. The stock has broken out of a 3-week trading range and has set a new high for the year.
For comments and feedback contact: editorial@rttnews.com
Business News